Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID- 19 Mortality Rate in a Dose-Response Manner
Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects Published: August 31, 2022 DOI: 10.7759/cureus.28624 Cite this article as: Kerr L, Baldi F, Lobo R, et al. (August 31, 2022) Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects. Cureus 14(8): e28624. doi:10.7759/cureus.28624 Read More→